Skip to content

Charles Christopher Donner, M.D.

NPI 1245242197ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Santa Barbara, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Santa Barbara, California, licensed in CA, with an NPI issued in August 2006. Their prescriptions cost Medicare Part D more than their services did: $326,504 for 1,953 claims, against $127,052 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 3 companies reporting payments in 2024, $74.38 in all, mostly food and beverage.

Overview

NPI1245242197
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedAug 12, 2006
Last updated in NPPESFeb 4, 2019

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients725
Services billed7,827 across 24 procedure codes
Paid by Medicare$127,052

Part D prescriptions in 2024

Prescriptions (claims)1,953 · 5,217 30-day fills
Patients490
Total drug cost$326,504
Generic share44% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$74.38 · 4 payments from 3 companies

Top paying companies in 2024

What the 2024 payments were for

  • Food and Beverage$74.38 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Santa Barbara

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →